Intest Res.  2022 Oct;20(4):389-391. 10.5217/ir.2022.00117.

Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education

• Kim S
• Koh SJ

• KMID: 2535814
• DOI: http://doi.org/10.5217/ir.2022.00117

Reference

1. Dorrington AM, Selinger CP, Parkes GC, Smith M, Pollok RC, Raine T. The historical role and contemporary use of corticosteroids in inflammatory bowel disease. J Crohns Colitis. 2020; 14:1316–1329.

2. Lewis JD, Scott FI, Brensinger CM, et al. Increased mortality rates with prolonged corticosteroid therapy when compared with antitumor necrosis factor-α-directed therapy for inflammatory bowel disease. Am J Gastroenterol. 2018; 113:405–417.

3. Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019; 68(Suppl 3):s1–s106.

4. Raine T, Bonovas S, Burisch J, et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis. 2022; 16:2–17.

5. Torres J, Bonovas S, Doherty G, et al. ECCO guidelines on therapeutics in Crohn’s disease: medical treatment. J Crohns Colitis. 2020; 14:4–22.

6. Choi CH, Moon W, Kim YS, et al. Second Korean guidelines for the management of ulcerative colitis. Intest Res. 2017; 15:7–37.

7. Park Y, Choi CH, Kim HS, et al. Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study. Intest Res. 2022; 20:452–463.

8. Sicilia B, Arias L, Hontoria G, García N, Badia E, Gomollón F. Are steroids still useful in immunosuppressed patients with inflammatory bowel disease? A retrospective, population-based study. Front Med (Lausanne). 2021; 8:651685.

9. Keller R, Mazurak N, Fantasia L, et al. Quality of life in inflammatory bowel diseases: it is not all about the bowel. Intest Res. 2021; 19:45–52.

10. Fudman DI, Perez-Reyes AE, Niccum BA, Melmed GY, Khalili H. Interventions to decrease unplanned healthcare utilization and improve quality of care in adults with inflammatory bowel disease: a systematic review. Clin Gastroenterol Hepatol. 2022; 20:1947–1970.